腕管松解术拟议质量指标能否揭示重要质量差距且是否可靠
本研究利用2018年Optum大型商业保险理赔数据库,纳入28083例患者首次腕管松解术,评估美国骨科医师学会提出的两项质量指标。避免辅助手术指标中位执行率为100%,无重要质量差距;避免常规诊所作业/物理治疗指标中位执行率为89%,存在较大质量差距,且两项指标信噪比和分半信度均超过美国国家质量论坛0.60的最低标准。
要点
- 避免辅助手术指标中位执行率100%,仅8%医生执行率低于100%,无重要质量差距。
- 避免常规诊所作业/物理治疗指标中位执行率89%,25%医生执行率低于75%,存在质量差距。
- 两项指标信噪比中位数分别为1.00和0.86,分半信度分别为0.87和0.75,均超过0.60。
核心结论
- 避免腕管松解术中辅助手术的指标缺乏重要质量差距,不太可能用于推动质量改进。
- 避免术后常规使用诊所作业/物理治疗的指标显示较大质量差距且信度很好,可能有助于质量监测和改进。
研究设计与样本
- 回顾性比较研究,使用2018年Optum Clinformatics® Data Mart大型全国商业保险理赔数据库。
- 纳入28083例患者首次腕管松解术,由7236名外科医生施行;医生层面分析限于1740名(24%)至少有5例腕管松解术的医生所治疗的18622例(66%)患者。
主要发现
- 18622例腕管松解术中2%(308例)涉及辅助手术;所有病例量分层中位执行率均为100%(IQR 100%至100%)。
- 至少5例的1740名医生中,8%(144名)执行率低于100%,5%(84名)低于90%。
- 至少5例的1740名医生中,避免常规治疗指标中位执行率为89%(IQR 75%至100%),25%(435名)执行率低于75%。
- 接受诊所作业/物理治疗的患者中大多数人术后6周内仅就诊1次。
关键数值与推荐
- 避免辅助手术指标中位信噪比1.00(IQR 1.00至1.00),分半信度0.87(95%CI 0.85至0.88)。
- 避免常规作业/物理治疗指标中位信噪比0.86(IQR 0.67至1.00),分半信度0.75(95%CI 0.73至0.77)。
- 两项指标信度统计均超过美国国家质量论坛0.60的新兴最低标准。
- 参照CMS标准,中位执行率大于95%视为指标「触顶」,进一步提升质量机会低。
临床怎么用
- 原文指出,随着医疗系统和支付方使用第二项指标(避免常规使用诊所作业/物理治疗)来鼓励遵循临床实践指南,考虑有多少接受作业/物理治疗的患者应被视为常规实践从而与指南不一致将至关重要。
- 原文指出,该指标的价值或潜在危害取决于这一判断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American Academy of Orthopaedic Surgeons recently proposed quality measures for the initial surgical treatment of carpal tunnel syndrome (CTS). One measure addressed avoidance of adjunctive surgical procedures during carpal tunnel release; and a second measure addressed avoidance of routine use of clinic-based occupational and/or physical therapy (OT/PT) after carpal tunnel release. However, for quality measures to serve their intended purposes, they must be tested in real-world data to establish that gaps in quality exist and that the measures yield reliable performance information. QUESTIONS/PURPOSES: (1) Is there an important quality gap in clinical practice for avoidance of adjunctive surgical procedures during carpal tunnel release? (2) Is there an important quality gap in avoiding routine use of clinic-based occupational and/or physical therapy after carpal tunnel release? (3) Do these two quality measures have adequate beta-binomial signal-to-noise ratio (SNR) and split-sample reliability (SSR)? METHODS: This retrospective comparative study used a large national private insurance claims database, the 2018 Optum Clinformatics® Data Mart. Ideally, healthcare quality measures are tested within data reflective of the providers and payors to which the measures will be applied. We previously tested these measures in a large public healthcare system and a single academic medical center. In this study, we sought to test the measures in the broader context of patients and providers using private insurance. For both measures, we included the first carpal tunnel release from 28,083 patients performed by one of 7236 surgeons, irrespective of surgical specialty (including, orthopaedic, plastic, neuro-, and general surgery). To calculate surgeon-level descriptive and reliability statistics, analyses were focused on the 66% (18,622 of 28,083) of patients who received their procedure from one of the 24% (1740 of 7236) of surgeons with at least five carpal tunnel releases in the database. No other inclusion/exclusion criteria were applied. To determine whether the measures reveal important gaps in treatment quality (avoidance of adjunctive procedures and routine therapy), we calculated descriptive statistics (median and interquartile range) of the performance distribution stratified by surgeon-level annual volume of carpal tunnel releases in the database (5+, 10+, 15+, 20+, 25+, and 30+). Like the Centers for Medicare & Medicaid Services (CMS), we considered a measure "topped out" if median performance was greater than 95%, meaning the opportunity for further quality improvement is low. We calculated the surgeon-level beta-binomial SNR and SSR for each measure, each stratified by the number of carpal tunnel releases performed by each surgeon in the database. These are standard measures of reliability in health care quality measurement science. The SNR quantifies the proportion of variance that is between rather than within surgeons, and the SSR is the correlation of performance scores when each surgeons' patients are split into two random samples and then corrected for sample size. RESULTS: We found that 2% (308 of 18,622) of carpal tunnel releases involved an adjunctive procedure. The results showed that avoidance of adjunctive surgical procedures during carpal tunnel release had a median (IQR) performance of 100% (100% to 100%) at all case volumes. Only 8% (144 of 1740) of surgeons with at least five cases in the database had less than 100% performance, and only 5% (84 of 1740) had less than 90% performance. This means adjunctive procedures were rarely performed and an important quality gap does not exist based on the CMS criterion. Regarding the avoidance of routine therapy, there was a larger quality gap: For surgeons with at least five cases in the database, median performance was 89% (75% to 100%), and 25% (435 of 1740) of these surgeons had less than 75% performance. This signifies that the measure is not topped out and may reveal an important quality gap. Most patients receiving clinic-based OT/PT had only one visit in the 6 weeks after surgery. Median (IQR) SNRs of the first measure, which addressed avoidance of adjunctive surgical procedures, and the second measure, which addresses avoidance of routine use clinic-based OT/PT, were 1.00 (1.00 to 1.00) and 0.86 (0.67 to 1.00), respectively. The SSR for these measures were 0.87 (95% CI 0.85 to 0.88) and 0.75 (95% CI 0.73 to 0.77), respectively. All of these reliability statistics exceed National Quality Forum's emerging minimum standard of 0.60. CONCLUSION: The first measure, the avoidance of adjunctive surgical procedures during carpal tunnel release, lacked an important quality gap suggesting it is unlikely to be useful in driving improvements. The second measure, avoidance of routine use of clinic-based OT/PT, revealed a larger quality gap and had very good reliability, suggesting it may be useful for quality monitoring and improvement purposes. CLINICAL RELEVANCE: As healthcare systems and payors use the second measure, avoidance of routine use of clinic-based OT/PT, to encourage adherence to clinical practice guidelines (such as provider profiling, public reporting, and payment policies), it will be critically important to consider what proportion of patients receiving OT/PT should be considered routine practice and therefore inconsistent with guidelines. The value or potential harm of this measure depends on this judgement.
引用
- Harris AHS, Ding Q, Trickey AW, et al. Do Proposed Quality Measures for Carpal Tunnel Release Reveal Important Quality Gaps and Are They Reliable? Clin Orthop Relat Res. 2022. PMID: 35274625. doi:10.1097/CORR.0000000000002175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。